To bias or not to bias in oncology clinical trials: Perspectives on design, endpoint selection, and reporting
نویسندگان
چکیده
Developing drugs for cancer is a process as complex the disease itself. At planning stage of clinical trial an oncology drug, thorough and careful consideration must be given to choosing right study design endpoints/estimands, any bias introduced at outset would cascade down analysis eventually reporting results. The common designs drugs, their challenges, current perspectives (and dilemmas) in industry on biases, roles medical writers facing these challenges are discussed this article.
منابع مشابه
Bias in reporting of randomised clinical trials in oncology.
BACKGROUND Bias in reporting efficacy and toxicity in clinical trials may impact treatment decisions. Here, we report quality of reporting of efficacy and of toxicity in articles describing randomised controlled trials (RCTs) of cancer therapy and the association between biased reporting and study results, funding and financial relationships of the authors with the sponsor. MATERIALS AND METH...
متن کاملPsychophysics of remembering: to bias or not to bias.
Delayed matching to sample is typically a two-alternative forced-choice procedure with two sample stimuli. In this task the effects of varying the probability of reinforcers for correct choices and the resulting receiver operating characteristic are symmetrical. A version of the task where a sample is present on some trials and absent on others is analogous to a yes/no recognition task. We desc...
متن کاملSelection Bias in reporting the prevalence of Transfusion Transmitted Infection Diseases in Iranian Hemophiliacs
متن کامل
Selection bias in clinical stroke trials depending on ability to consent
BACKGROUND Clinical trials are the hallmark of evidence-based medicine, but recruitment is often challenging, especially in stroke trials investigating patients not being able to give informed consent. In some nations, ethics committees will not approve of inclusion in a clinical study via consent of a legal representative. The ethical dilemma of including or excluding those patients has not be...
متن کاملTo Adjust or Not to Adjust? Sensitivity Analysis of M-Bias and Butterfly-Bias
M-Bias,” as it is called in the epidemiologic literature, is the bias introduced by conditioning on a pretreatment covariate due to a particular “M-Structure” between two latent factors, an observed treatment, an outcome, and a “collider.” This potential source of bias, which can occur even when the treatment and the outcome are not confounded, has been a source of considerable controversy. We ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medical Writing
سال: 2023
ISSN: ['2047-4814', '2047-4806']
DOI: https://doi.org/10.56012/ejyj3404